NCT04800822 2024-10-22PF-07284892 in Participants With Advanced Solid TumorsPfizerPhase 1 Terminated53 enrolled
NCT01960023 2021-10-27Safety and Efficacy Study of Neratinib and Cetuximab to Treat Patients With Quadruple Wild-Type Metastatic Colorectal CancerNSABP Foundation IncPhase 1/2 Withdrawn
NCT01640444 2019-04-11VISNU-2Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)Phase 2 Completed240 enrolled
NCT01252628 2018-05-16Phase 1 and 2 Study of PX-866 and CetuximabSeagen Inc.Phase 1/2 Completed178 enrolled